Literature DB >> 1324848

Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver.

T Gebel1, M Arand, F Oesch.   

Abstract

The process of peroxisome proliferation in rodent liver by hypolipidemic compounds and related substances has recently been shown to be receptor-mediated. In the present study, we have examined the effect of oral administration of the strong peroxisome proliferator fenofibrate on the hepatic expression level of the peroxisome proliferator activated receptor (PPAR) in rats. Immunoblots of rat liver cytosols and nuclear extracts using antibodies raised against recombinant PPAR/beta-galactosidase fusion proteins revealed a pronounced increase in the amount of PPAR protein in response to fenofibrate treatment. This induction could also be confirmed at the level of RNA by Northern blotting. A time-course investigation showed a delayed accumulation of mRNA in response to the treatment, starting on day 2 after a latency period of at least one day. Thus, induction of the PPAR as a response to peroxisome proliferators represents one important dimension of the pleiotropic effects of peroxisome proliferators.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324848     DOI: 10.1016/0014-5793(92)80734-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.

Authors:  Benjamin V Park; Fan Pan
Journal:  Cell Mol Immunol       Date:  2015-09       Impact factor: 11.530

2.  Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage.

Authors:  Arantza Ibabe; Eider Bilbao; Miren P Cajaraville
Journal:  Histochem Cell Biol       Date:  2004-12-23       Impact factor: 4.304

3.  Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression.

Authors:  Jean-Marie Heydel; Philippe Garnier; Philippe Faure; Yves Artur
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-04-04       Impact factor: 2.441

4.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

5.  A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

Authors:  M N Sack; D L Disch; H A Rockman; D P Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.

Authors:  Ana Soria; Maria del Carmen González; Hubert Vidal; Emilio Herrera; Carlos Bocos
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

Review 7.  Peroxisome proliferator-activated receptor alpha and hypertensive heart disease.

Authors:  Maria J Goikoetxea; Javier Beaumont; Javier Díez
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.

Authors:  S Bonilla; A Redonnet; C Noël-Suberville; R Groubet; V Pallet; P Higueret
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

9.  The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression.

Authors:  T Gulick; S Cresci; T Caira; D D Moore; D P Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival.

Authors:  A Chawla; M A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.